It seems that many of these readers are sympathetic to these businesses because they believe that providing healthcare benefits to their employees is just not something these companies can affordtodo without damaging their businesses, despite the millions in profit that many of these operations rake in each year.
Given the intrinsically high likelihood of failure, long-term survival requires the ability to advance a portfolio of products through clinical development, something that typically only fairly large companies can affordtodo.